Request Advisory Consultation

European Jurisdiction Comparison

Spain vs Greece for Fertility Treatment

Spain and Greece are established European fertility destinations, but country reputation alone should not determine the choice. Compare eligibility, donor frameworks, clinic governance, costs, travel, documentation, and continuity of care.

Who this guide is for

  • Patients comparing Spain and Greece
  • Couples evaluating donor-treatment pathways
  • Intended parents comparing European clinics
  • Families planning cross-border fertility treatment

Executive summary

Compare the pathway, not the destination label

Both countries offer established fertility sectors and international-patient services, but clinic quality, laboratory governance, communication, pricing, and treatment suitability vary within each country.

Jurisdiction-level rules matter, especially for eligibility, donor treatment, consent, and documentation. Clinic-level execution then determines how safely and transparently the pathway is delivered.

The strongest choice is the country-clinic combination that best aligns with the patient's medical needs, legal circumstances, budget, travel capacity, and continuity plan.

Comparison framework

Ten factors to assess

01

Regulatory framework

Spain

Spain regulates assisted reproduction through national legislation, including requirements for treatment centres, consent, donation, and permitted techniques. Clinic authorization and regional implementation should be verified directly.

Greece

Greece regulates medically assisted reproduction through national law and oversight by the Hellenic National Authority of Medically Assisted Reproduction. Clinic licensing and current operational status should be confirmed.

Questions to ask

  • Which authority licenses the clinic?
  • Is the clinic's licence current?
  • Which rules are national and which are clinic-specific?
  • How are complaints or incidents handled?
02

Eligibility and patient profile

Spain

Access may depend on the treatment requested, medical suitability, age, clinic policy, and the legal framework applying to the patient.

Greece

Access may depend on medical suitability, age, treatment type, required approvals, clinic policy, and current national rules.

Questions to ask

  • Does the clinic accept the patient's age and family circumstances?
  • Is prior approval required?
  • Are there treatment-specific restrictions?
  • Which eligibility rules could change before treatment begins?
03

Egg and sperm donation

Spain

Spain has an established donor-treatment sector. Donor anonymity, screening, matching, consent, and record-retention rules should be reviewed carefully with the clinic.

Greece

Greece also offers donor pathways. Current rules on donor identity, screening, matching, consent, and future information access should be confirmed before treatment.

Questions to ask

  • Is donation anonymous or identity-release?
  • What medical and genetic screening is performed?
  • How are donors matched?
  • What information may be available later?
04

Clinic and laboratory governance

Spain

Spain has a large fertility-treatment market with significant clinic choice. Patients should compare laboratory leadership, quality systems, traceability, and clinical accountability rather than relying on brand visibility.

Greece

Greece has a substantial assisted-reproduction sector overseen by a national authority. Patients should still verify laboratory governance, staffing, quality control, and clinic-specific accountability.

Questions to ask

  • Who leads the medical and embryology teams?
  • What quality-assurance systems are used?
  • How are specimens tracked and protected?
  • What happens if laboratory or treatment incidents occur?
05

Treatment protocols and add-ons

Spain

Clinics may offer a wide range of protocols and laboratory services. Recommendations should be linked to the patient's circumstances and supported by a clear explanation.

Greece

Clinics may also offer varied protocols and treatment add-ons. Patients should distinguish clinically necessary services from optional or promotional additions.

Questions to ask

  • Why is the proposed protocol appropriate?
  • Which add-ons are optional?
  • What evidence supports each recommendation?
  • Would another clinic recommend the same pathway?
06

Success-rate reporting

Spain

Published rates may use different outcomes, denominators, patient groups, donor categories, or reporting periods. Clinic comparisons require like-for-like definitions.

Greece

The same caution applies in Greece. A headline percentage should not be treated as proof of suitability or quality without understanding the underlying data.

Questions to ask

  • Is the rate pregnancy, ongoing pregnancy, or live birth?
  • Is it per cycle, retrieval, transfer, or patient?
  • Are donor and own-egg cycles separated?
  • Are age groups and cancellations disclosed?
07

Costs and package structure

Spain

Spain may offer broad clinic choice across different price levels. Medication, testing, donor services, genetic testing, freezing, storage, and future transfers may be separate.

Greece

Greece may also present competitive private treatment pricing. Full cost comparison should include the same exclusions, variable expenses, and repeat-treatment exposure.

Questions to ask

  • What is included in the written quotation?
  • Which services are mandatory but excluded?
  • How long is the quote valid?
  • What would a repeat attempt cost?
08

Travel and treatment logistics

Spain

Spain offers multiple major treatment hubs with broad international transport links, but the practical burden depends on clinic location, monitoring requirements, and treatment timing.

Greece

Greece also has established treatment centres and international access, though route availability, island or mainland location, seasonal travel, and local transport may affect planning.

Questions to ask

  • How many visits are required?
  • Can monitoring be completed at home?
  • How flexible must travel dates remain?
  • What happens if treatment is delayed?
09

Language and communication

Spain

Many clinics serving international patients provide English-language coordination, but written consent, emergency communication, and clinical records should be confirmed.

Greece

Many Greek clinics also support international patients. Patients should verify language access for medical discussions, consent documents, medication instructions, and follow-up.

Questions to ask

  • Who is the named coordinator?
  • Are all key documents available in an understandable language?
  • How are urgent questions handled?
  • Will complete records be supplied after treatment?
10

Continuity of care and documentation

Spain

Patients should confirm how records, prescriptions, monitoring plans, and follow-up instructions will be transferred to providers at home.

Greece

The same continuity planning is essential in Greece, especially when treatment changes, complications, or pregnancy follow-up must be managed after return.

Questions to ask

  • Who manages care before arrival and after return?
  • How quickly are records released?
  • Who handles complications or urgent concerns?
  • Are certified translations needed?

Spain may fit when

  • The patient values a broad clinic market and multiple major treatment hubs.
  • The preferred donor or treatment pathway is available and clearly explained.
  • Direct travel and clinic coordination are practical from the patient's location.
  • The selected clinic demonstrates strong laboratory and communication governance.
  • The complete cost and repeat-treatment plan remains acceptable.

Greece may fit when

  • The patient's pathway aligns with current Greek eligibility and approval requirements.
  • A suitable clinic offers clear donor, laboratory, and treatment governance.
  • The travel plan remains practical despite timing or seasonal changes.
  • The complete package and additional costs are transparent.
  • Continuity of care and documentation can be coordinated reliably.

Practical process

A five-step decision method

  1. 01

    Confirm jurisdiction-level suitability

    Verify current eligibility, donor rules, treatment availability, documentation, and any approvals required in each country.

  2. 02

    Compare equivalent clinics

    Shortlist clinics with similar services, patient profiles, laboratory capabilities, and treatment pathways.

  3. 03

    Normalize success-rate definitions

    Compare the same outcome, denominator, age group, donor category, and reporting period.

  4. 04

    Build a complete cost and travel model

    Include treatment, medication, testing, donor, storage, transfer, travel, accommodation, documentation, and contingency costs.

  5. 05

    Assess execution risk

    Review communication, scheduling, local monitoring, record transfer, legal review, follow-up, and the consequences of delay or cancellation.

Red flags

Reasons to pause before choosing a destination

The decision is based only on country reputation or package price.

The clinic guarantees pregnancy or live birth.

Donor identity, screening, consent, or record-retention rules are unclear.

The clinic cannot identify its licensing authority or current licence.

Success rates are presented without definitions or patient context.

The quotation omits medication, storage, transfers, or mandatory services.

Consent documents are not available in a language the patient understands.

There is no plan for monitoring before travel or follow-up after return.

Travel dates are treated as fixed despite possible clinical changes.

The patient has not confirmed that the pathway is recognized at home.

Related resources

Continue your research

Frequently asked questions

FAQ

Is Spain or Greece better for IVF?

Neither country is inherently better for every patient. Suitability depends on eligibility, donor needs, treatment type, clinic governance, costs, travel, documentation, and continuity of care.

Which country is usually cheaper?

Prices vary significantly by clinic and pathway. Compare complete costs, including medication, donor services, testing, freezing, storage, transfers, travel, accommodation, and repeat-treatment exposure.

Can single women access treatment in Spain or Greece?

Access may be possible, but current eligibility depends on national law, treatment type, age, medical suitability, and clinic policy. Confirm directly before relying on general information.

Are egg donors anonymous in Spain and Greece?

Both countries have donor frameworks, but current identity, disclosure, consent, screening, and record-retention rules should be confirmed with the clinic and qualified legal professionals.

Should success rates decide between Spain and Greece?

No. Rates are useful only when definitions, patient groups, donor use, age, treatment type, and denominators match. Clinic governance and patient suitability remain equally important.

Does FertilityCareHub recommend one country?

No. FertilityCareHub provides a structured comparison framework rather than a universal ranking or recommendation.

Private strategic advisory

Compare Spain and Greece against your actual pathway

FertilityCareHub helps structure decisions around eligibility, donor pathways, clinic governance, success-rate context, total costs, travel, documentation, and continuity of care.

Request a strategy review

Review and methodology

Last reviewed: July 15, 2026. Laws, clinic licences, age requirements, donor rules, prices, travel access, and treatment availability can change. Confirm current information directly.

Important limitation

FertilityCareHub does not provide medical, legal, tax, or financial advice and does not guarantee outcomes. Confirm medical decisions with licensed clinicians and legal questions with qualified professionals.

Read the full disclaimer